Expert Panel Discussion – De-Risking RNA Delivery Platforms Through Uncovering the Most Suitable Platforms for Your RNA Payloads to Ensure Effective Treatment
Time: 9:00 am
day: Day 1
Details:
- With an array of nonviral delivery carriers in development, how do you identify which is the most suitable method for your RNA therapeutic?
- How can the field leverage and learn from approved carriers, such as LNPs, to overcome 2024 IP complexities?
- When developing a novel delivery vehicle, how is the field de-risking their platforms to ensure a commercial success given the crowded IP landscape?
